Inhibitors of interleukin 1-β converting enzyme

Details Inhibitors of interleukin 1-β converting enzyme Inhibitors of interleukin 1-β converting enzyme

2005-12-13

2005-12-13

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S503000

Reexamination Certificate

active

06974809

ABSTRACT:
The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme (“ICE”). This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against interleukin-1-(“IL-1”), apoptosis-, interferon-γ inducing factor-(IGIF), interferon-γ-(“IFN-γ”) mediated diseases, excess dietary alcohol intake diseases, or viral diseases, including inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases. This invention also relates to methods for inhibiting ICE activity and decreasing IGIF production and IFN-γ production and methods for treating interleukin-1, apoptosis- and interferon-γ-mediated diseases using the compounds and compositions of this invention. This invention also relates to methods of preparing the compounds of this invention.

REFERENCES:
patent: WO 95/35308 (1995-12-01), None
P.G. Arndt et al., “Expression of Interleukin-1β in the Lung after Endotoxemia or Hemorrhage-Induced Acute Lung Injury,”Am. J. Respir. Cell Mol. Biol.,22, pp. 708-713 (2000).
M.R. Bani, “Effect of Interleukin-1-beta on Metastasis Formation in Different Tumor Systems,”J. Natl. Cancer Inst.83, pp. 119-123 (1991).
M.A. Boermeester et al., “Interleukin-1 Blockade Attenuates Mediator Release and Dysregulation of the Hemostatic Mechanism During Human Sepsis,”Arch. Surg.,130, pp. 739-748 (1995).
Y. Cheng et al., “Caspase Inhibitor Affords Neuroprotection with Delayed Administration in a Rat Model of Neonatal Hypoxic-Ischemic Brain Injury,”J. Clin. Invest.,101, pp. 1992-1999 (1998).
F.E., Dewhirst et al., “Purification and Partial Sequence of Human Osteoclast-activating Factor: Identity with Interleukin-1β,”J. Immunol.,135, pp. 2562-2568 (1985).
M. Endres et al., “Attenuation of Delayed Neuronal Death After Mild Focal Ischemia in Mice by Inhibition of the Caspase Family,”J. Cereb. Blood Flow and Metab.,18, pp. 238-247 (1998).
Z. Estrov & M. Talpaz, “Role of Interleukin-β Converting Enzyme (ICE) in Acute Myelogenous Leukemia Cell Proliferation and Programmed Cell Death,”Leukemia&Lymophoma,24, pp. 379-391 (1997).
R.M. Friedlander et al., “ICE, Neuronal Apoptosis and Neurodegeneration,”Cell Death and Differentiation,5, pp. 823-831 (1998).
R.M. Friedlander, “Role of Caspase 1 in Neurologic Disease,”Arch. Neurol.,57, pp. 1273-1276 (2000).
T. Geiger et al., “Neutralization of Interleukin-1β Activity in vivo with a Monoclonal Antibody Alleviates Collagen-induced Arthritis in DBA/1 Mice and Prevents the Associated Acute-phase Response,”Clin. Exper. Rheumatol.,11, pp. 515-522 (1993).
S.R. Grobmeyer et al., “Peptidomimetic Fluoromethylketone Rescues Mice from Lethal Endotoxic Shock,”Molec. Med.,5, pp. 585-594 (1999).
G. Ku et al., “Interleukin-1β Converting Enzyme Inhibition Blocks Progression of Type II Collagen-Induced Arthritis in Mice,” Cytokine, 8, pp. 377-386 (1996).
H.Y. Lan, “Interleukin-1 Receptor Antagonist Halts the Progression of Established Crescentic Glomerulonephritis in the Rat,”Kidney Internat.,47, pp. 1303-1309 (1995).
M.E. McAlindon et al., “Investigation of the Expression of IL-1β Converting Enzyme and Apoptosis in Normal and Inflammatory Bowel Disease (IBD) Mucosal Macrophages,”Clin. Exp. Immunol.,116, pp. 251-257 (1999).
P.L. McCarthy, “Inhibition of Interleukin-1 by an Interleukin-1 Receptor Antagonist Prevents Graft-Versus Host Disease,”Blood,78, pp. 1915-1918 (1991).
B. E. Miller et al., “Inhibition of Mature IL-1β Production in Murine Macrophages and a Murine Model of Inflammation by WIN 67694, an Inhibitor of IL-1β Converting Enzyme,”J. Immunol.,154, pp. 1331-1338 (1995).
D.K. Miller et al., “The IL-1β Converting Enzyme as a Therapeutic Target,”Annals N.Y. Acad. Sci.,696, pp. 133-148 (1993).
J. Norman et al., “Severity and Mortality of Experimental Pancreatitis are Dependent on Interleukin-1 Converting Enzyme (ICE),”J. Interferon Cytokine Res.,17, pp. 113-118 (1997).
K. Ohlsson et al., “Interleukin-1 Receptor Antagonist Reduces Mortality from Endotoxic Shock,”Nature,348, pp. 550-552 (1990).
B.J. Pomerantz et al., “Inhibition of Caspase 1 Reduces Human Myocardial Ischemic Dysfunction via Inhibition of IL-18 and IL-1β,”Proc. Natl. Acad. Sci.,98, pp. 2871-2876 (2001).
N. Rouquet et al., “ICE Inhibitor YVADcmk is a Potent Therapeutic Agent Against In Vivo Liver Apoptosis,”Curr. Biol.,6, pp. 1192-1195 (1996).
P.J. Sansonetti et al., “Caspase-1 Activation of IL-1β and IL-18 are Essential forShigella flexneri-Induced Inflammation,”Immunity,12, pp. 581-590 (2000).
G.S. Schierle et al., “Caspase Inhibition Reduces Apoptosis and Increases Survival of Nigral Transplants,”Nature Med.,5, pp. 97-100 (1999).
B. Siegmund, “Interleukin-1β Converting Enzyme (Caspase-1) in Intestinal Inflammation,”Biochem. Pharmacol.,64, pp. 1-8 (2002).
F. Vidal-Vanaclocha et al., “IL-18 Regulates IL-1β-dependent Hepatic Melanoma Metastasis via Vascular Cell Adhesion Molecule-1,”Proc. Natl. Acad. Sci.,97, pp. 734-739 (2000).
H. Yaoita et al., “Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor,”Circulation,97, pp. 276-281 (1998).

Affiliated with

Also associated with

Rating

Inhibitors of interleukin 1-β converting enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of interleukin 1-β converting enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of interleukin 1-β converting enzyme will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3515188